Antiretroviral-based HIV prevention strategies for women

被引:7
|
作者
Chirenje, Z. Mike [1 ]
Marrazzo, Jeanne [2 ]
Parikh, Urvi M. [3 ]
机构
[1] Univ Zimbabwe UZ UCSF, Dept Obstet & Gynaecol, Harare, Zimbabwe
[2] Univ Washington, Div Allergy & Infect Dis, Seattle STD HIV Prevent Training Ctr, Seattle, WA 98195 USA
[3] Univ Pittsburgh, Microbicide Trials Network Virol Core, Pittsburgh, PA 15260 USA
关键词
antiretroviral agents; biological plausibility; chemoprophylaxis; post-exposure prophylaxis; pre-exposure prophylaxis; topical microbicides; HUMAN-IMMUNODEFICIENCY-VIRUS; POSTEXPOSURE PROPHYLAXIS; MALE CIRCUMCISION; SIV INFECTION; GENITAL-TRACT; TRANSMISSION; MACAQUES; PREEXPOSURE; TENOFOVIR; THERAPY;
D O I
10.1586/ERI.10.79
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Almost three decades have elapsed since researchers identified HIV as the cause of AIDS, with current estimates from UNAIDS that 33.4 million adults were living with HIV/AIDS in 2008. Two-thirds of this burden of disease is in Sub-Saharan Africa, and 60% of those infected are women. The disease still remains incurable and current prevention strategies including abstinence, male/female condom use and male circumcision are only partially effective. New strategies to curb the epidemic are urgently needed. Scientists are diligently exploring HIV prevention methods that are safe, effective and affordable. These new biological interventions include oral pre-exposure prophylaxis using oral antiretroviral (ARV) drugs, ARV treatment in HIV-infected persons to reduce transmission and topical ARV-based microbicide formulations.
引用
收藏
页码:1177 / 1186
页数:10
相关论文
共 50 条
  • [31] Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention
    Irungu, Elizabeth M.
    Heffron, Renee
    Mugo, Nelly
    Ngure, Kenneth
    Katabira, Elly
    Bulya, Nulu
    Bukusi, Elizabeth
    Odoyo, Josephine
    Asiimwe, Stephen
    Tindimwebwa, Edna
    Celum, Connie
    Baeten, Jared M.
    [J]. BMC INFECTIOUS DISEASES, 2016, 16
  • [32] Prevention of Mother-to-Child Transmission of HIV: Antiretroviral Strategies
    Read, Jennifer S.
    [J]. CLINICS IN PERINATOLOGY, 2010, 37 (04) : 765 - +
  • [33] Reply to Heise and Philpott: The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics
    Blower, Sally
    Wilson, D. P.
    Coplan, P. M.
    Wainberg, M. A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (44) : E74 - E74
  • [34] Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission
    Cooper, ER
    Charurat, M
    Mofenson, L
    Hanson, IC
    Pitt, J
    Diaz, C
    Hayani, K
    Handelsman, E
    Smeriglio, V
    Hoff, R
    Blattner, W
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (05) : 484 - 494
  • [35] The key role of adherence for the effectiveness of antiretroviral-based prevention: state of the science and implications for the Asia-Pacific region
    Amico, K. Rivet
    [J]. SEXUAL HEALTH, 2014, 11 (02) : 155 - 165
  • [36] Specific antiretroviral therapy of pregnant women for the prevention of vertical HIV transmission
    Isaeva, G
    [J]. AIDS, 1998, 12 : S95 - S95
  • [37] Women and the heterosexual transmission of HIV: Risks and prevention strategies
    Gavey, N
    McPhillips, K
    [J]. WOMEN & HEALTH, 1997, 25 (02) : 41 - 64
  • [38] The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics (vol 105, pg 9835, 2008)
    Wilson, David P.
    Coplan, Paul M.
    Wainberg, Mark A.
    Blower, Sally M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (16) : 6879 - 6879
  • [39] Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism
    Cheu, Ryan K.
    Gustin, Andrew T.
    Lee, Christina
    Schifanella, Luca
    Miller, Charlene J.
    Ha, Avie
    Kim, Casey
    Rodriguez, Violeta J.
    Fischl, Margaret
    Burgener, Adam D.
    Arnold, Kelly B.
    Alcaide, Maria L.
    Klatt, Nichole R.
    [J]. PLOS PATHOGENS, 2020, 16 (12)
  • [40] Impact of Vaginal Bacteria Communities on Antiretroviral-based PrEP Drug Metabolism
    Cheu, Ryan K.
    Gustin, Andrew
    Miller, Charlene J.
    Rodriguez, Violeta
    Fischl, Margaret
    Alcaide, Maria L.
    Klatt, Nichole R.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 14 - 14